AUSTIN, Texas and VANCOUVER, Washington, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Absci, a clinical-stage biotech company advancing novel therapeutics with generative AI, today announced a collaboration ...
Hosted on MSN
Absci Corporation Taps Advanced Micro Devices Inc. (AMD) Chip for AI Drug Discovery Platform
Advanced Micro Devices Inc. (NASDAQ:AMD) is one of the best tech stocks to buy, according to Cathie Wood. On September 11, Absci Corporation (ABSI), a clinical-stage biotechnology firm, announced a ...
On track to initiate Ph1/2a trial for ABS-201 (anti-PRLR for androgenetic alopecia) in December; hosting KOL seminar on December 11 Expanding ABS-201 strategy to pursue endometriosis as additional ...
GAAP revenue was $0.6 million for Q2 2025, missing GAAP revenue estimates by 52.3% and Revenue for the three months ended June 30, 2025, was $0.6 million, compared to $1.3 million in the same period ...
Hosted on MSN
Absci Reports Strong Q2 2025 Financial Results
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from AbSci ( ...
(RTTNews) - Absci, a clinical-stage biotech focused on AI-powered therapeutics, announced a collaboration with Oracle Cloud Infrastructure - OCI and Advanced Micro Devices, Inc. (AMD) to enhance its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback